BioCatalystWatch
CTMXWorkspace / CTMX / OverviewCompany library
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. (CTMX)

Website

Price
Market cap
Next catalystMonotherapy data update expected in January 2027Varsetatug masetecan — colorectal cancer development · Phase 1 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

CX-801

PreINDP1P2P3FilingApproved
Upcoming / outlook

varsetatug masetecanVarsetatug masetecan — colorectal cancer development

EpCAM

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

varsetatug masetecanVarsetatug masetecan — colorectal cancer development

EpCAM

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CX-801

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

varsetatug masetecan

EpCAM

PreINDP1P2P3FilingApproved
CX-908

T-cell engager

CDH3 (P-cadherin) × CD3

PreINDP1P2P3FilingApproved

History / paused

CD71 (transferrin receptor)

PreINDP1P2P3FilingApproved

CD71 (transferrin receptor)

PreINDP1P2P3FilingApproved

CD71 (transferrin receptor)

PreINDP1P2P3FilingApproved

CD71 (transferrin receptor)

PreINDP1P2P3FilingApproved

CTLA-4

PreINDP1P2P3FilingApproved

CTLA-4

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CTMX PR & News

PR & News

CTMX SEC archive